http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
X-energy Closes Upsized $700 Million Series C-1 Financing Round to Accelerate the Development of Advanced Small Modular Nuclear Technology
-
Texas Mineral Resources Chairman Anthony Marchese Invited to Testify at the U.S. Senate Committee on Commerce, Science & Transportation Hearing on February 12th
-
NCR Atleos’ Cashzone Network Expands into Italy, Enabling Convenient Access to Cash
-
The UNH Interoperability Lab Receives TISAX® Label to Further Support Automotive Testing
-
Societe Generale: Fourth quarter & 2024 full year results
-
All-new, All-electric 2025 Jeep® Wagoneer S Limited: Well-equipped, Competitively Priced and Now Open for Orders
-
Alchemy Pay Expands Presence in Korea through Investment in EZPG Co., Ltd. (이지피쥐), Acquiring Electronic Financial Business Registration
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NXT
-
Body and Mind Inc. Provides Update on Financial Reporting
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Light & Wonder, Inc. Investors to Inquire About Securities Class Action Investigation - LNW
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- IIPR
-
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
-
ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
Renesas Reports Financial Results for the Year Ended December 31, 2024
-
Renesas Announces Consolidated Forecasts
-
Notice Concerning the Difference between Financial Results for the Year Ended December 31, 2024 and Results in the Previous Period
-
ROSEN, A LEADING LAW FIRM, Encourages Block, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SQ, XYZ
-
LeddarTech Announces Listing Transfer to the Nasdaq Capital Market; Comments on Recent Positive Business Developments
-
Recursion Pharmaceuticals (RXRX) reports date from phase 2 of REC-994 studies
-
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
-
The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine
-
PepsiCo Declares Quarterly Dividend
-
Becton Dickinson (BDX) to Separate Biosciences and Diagnostic Solutions Business
-
BD Reports First Quarter Fiscal 2025 Financial Results
-
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
-
Bain Capital Announces Majority Investment in Milacron, a Leading Global Provider of Highly Engineered Plastic Processing Solutions
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ModivCare Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MODV
-
Encompass Health Named One of Fortune's World's Most Admired Companies for Fifth Consecutive Year
-
BrightView Reports First Quarter Fiscal 2025 Results, Expanded Margins, Reaffirms 2025 Guidance
-
Blackbaud Announces Date of Fourth Quarter and Full Year 2024 Financial Results
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025
-
Universal Technical Institute Reports Fiscal Year 2025 First Quarter Results
-
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Polestar Automotive Holding UK PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - PSNY
-
ROSEN, A LEADING LAW FIRM, Encourages Paladin Energy Ltd Investors to Inquire About Securities Class Action Investigation - PALAF
-
Over $17 million in medical debt wiped out for Arizonans
-
ROSEN, A LEADING LAW FIRM, Encourages FTAI Aviation Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTAI
-
ABA Facing Challenges and Opportunities Head-On, Says President Bay
-
Banks sell down $5.5 billion of Musk's X debt to investors, source says
-
Lightbeam Health Awarded Best in KLAS for Remote Patient Monitoring
-
ROSEN, A LEADING LAW FIRM, Encourages Tungray Technologies Inc Investors to Inquire About Securities Class Action Investigation - TRSG
-
Top Trump prosecutor in DC, who was present at Capitol riot, dropped US case against rioter
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Integral Ad Science Holding Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IAS
-
Metrie Announces Several Executive Leadership Team Promotions
-
Zyxel Networks Offers Partners a Risk-Free Trial of Nebula Cloud Management Solution for Small- and Medium-Sized Businesses
-
Synergetics.ai releases AgentWorks™ - a suite for Decentralized Autonomous AI Agents, and Agent-to-Agent Transactions
-
Guardian is Recipient of DALBAR's Insurance Service Award for 10th Consecutive Year for Outstanding Policyholder Service
-
Core and More Technologies Reports Record-Breaking Year-Over-Year Digital Marketing Performance Growth
